The Road Ahead
The underlying case centered on Janssen’s allegedly unlawful promotion of HIV treatments Prezista and Intelence, one of the stiffest FCA verdicts in U.S. history. A brief from the whistleblowers is due Sept. 17, with J&J’s reply scheduled for Oct. 27.
Janssen is represented by Covington & Burling LLP.
Penelow and Brancaccio are represented by Reese Marketos LLP, Berger Montague, and Kellogg Hansen Todd Figel & Frederick PLLC.
The DOJ’s Civil Division team includes Daniel Winik, Charles W. Scarborough, Michael S. Raab, and Brett A. Shumate.
Representatives for J&J declined immediate comment.
